Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 8, 2025
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation
Mayukha Bathini, Diana Bocaniciu, Fraser D Johnson, et al.
Nature Communications
|
August 27, 2025
Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells
Alexander Kowar, Jonas P Becker, Rossella Del Pizzo, et al.
Nature Communications
|
June 13, 2019
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
Kim R Kampen, Laura Fancello, Tiziana Girardi, et al.
Cancer Research
|
May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production
Remco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.
Nature Cell Biology
|
June 7, 2024
Valine aminoacyl-tRNA synthetase promotes therapy resistance in melanoma
Najla El-Hachem, Marine Leclercq, Miguel Susaeta Ruiz, et al.
Nucleic Acids Research
|
February 27, 2018
LncRNA-OIS1 regulates DPP4 activation to modulate senescence induced by RAS
Li Li, Pieter C van Breugel, Fabricio Loayza-Puch, et al.
Nature Communications
|
March 2, 2018
FcαRI co-stimulation converts human intestinal CD103<sup>+</sup> dendritic cells into pro-inflammatory cells through glycolytic reprogramming
Ivo S Hansen, Lisette Krabbendam, Jochem H Bernink, et al.
Science (New York, N.Y.)
|
May 16, 2024
DNA damage induces p53-independent apoptosis through ribosome stalling
Nicolaas J Boon, Rafaela A Oliveira, Pierré-René Körner, et al.
Immunity
|
January 4, 2025
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Julien Champagne, Morten M Nielsen, Xiaodong Feng, et al.
The Journal of Experimental Medicine
|
August 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Biorxiv : the Preprint Server for Biology
|
August 8, 2025
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation
Mayukha Bathini, Diana Bocaniciu, Fraser D Johnson, et al.
Nature Communications
|
August 27, 2025
Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells
Alexander Kowar, Jonas P Becker, Rossella Del Pizzo, et al.
Nature Communications
|
June 13, 2019
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
Kim R Kampen, Laura Fancello, Tiziana Girardi, et al.
Cancer Research
|
May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production
Remco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.
Nature Cell Biology
|
June 7, 2024
Valine aminoacyl-tRNA synthetase promotes therapy resistance in melanoma
Najla El-Hachem, Marine Leclercq, Miguel Susaeta Ruiz, et al.
Nucleic Acids Research
|
February 27, 2018
LncRNA-OIS1 regulates DPP4 activation to modulate senescence induced by RAS
Li Li, Pieter C van Breugel, Fabricio Loayza-Puch, et al.
Nature Communications
|
March 2, 2018
FcαRI co-stimulation converts human intestinal CD103<sup>+</sup> dendritic cells into pro-inflammatory cells through glycolytic reprogramming
Ivo S Hansen, Lisette Krabbendam, Jochem H Bernink, et al.
Science (New York, N.Y.)
|
May 16, 2024
DNA damage induces p53-independent apoptosis through ribosome stalling
Nicolaas J Boon, Rafaela A Oliveira, Pierré-René Körner, et al.
Immunity
|
January 4, 2025
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Julien Champagne, Morten M Nielsen, Xiaodong Feng, et al.
The Journal of Experimental Medicine
|
August 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, et al.
Page
of 14